W Bryan Hill

Director W Bryan Hill purchased 21,803 shares of EQPT at $22.89; stock now at $20.44, -42.4% from 52-week high, amid $-29.0M net loss.

Director W Bryan Hill purchased 21,803 shares at $22.89 for a total value of $499,070.67, expanding his holdings by +155.8% to 35,794 shares post-transaction. The purchase occurred when EQPT is trading 42.4% below its 52-week high of $35.50 and down 39.4% over 90 days, a period of significant weakness. However, the company is currently unprofitable with $-29.0M net income in the latest quarter despite annual revenue growth of +16.3%, creating a mixed backdrop. Hill's cross-ticker track record shows 20 prior sells with a 90-day well-timed rate of 50.00%—neither demonstrating a pattern of foresight nor consistent misdirection—providing limited predictive context for this purchase.

CFO Hill W Bryan sold 20,366 shares of ALKT at $24.76; 5 of 5 prior ALKT sales were well-timed at the 90-day mark.

Hill W Bryan, CFO of Alkami Technology, sold 20,366 shares on 2025-09-02 at $24.76, reducing his holdings to 409,889 shares (-4.7% of pre-transaction holdings). The stock has since risen 16.0% over 30 days but remains 40.7% below its 52-week high of $42.22. What distinguishes this sale is the insider's prior timing pattern at this ticker: his 5 preceding sales at ALKT—spanning from 2024-12-03 through 2025-06-02—were all well-timed at the 90-day horizon, with negative 90-day returns ranging from -5.8% to -36.5%, indicating he sold before subsequent declines. This consistent pattern across all prior ALKT trades suggests the insider has demonstrated an ability to exit before unfavorable price movement at this specific stock. Separately, the company remains unprofitable (full-year net income was negative) despite strong 26.1% annual revenue growth and $112.1M in quarterly revenue, creating an environment where insider transaction signals may carry particular weight.

CFO Bryan Hill sold 20,365 shares of ALKT for $577.6K; stock down 31.4% from 52-week high, but insider's 5 prior ALKT sells all well-timed at 90-day mark.

Bryan Hill, CFO of Alkami Technology, sold 20,365 shares at $28.36 on 2025-06-02, reducing holdings by 4.5% to 430,255 shares. Notably, Hill's prior trades at ALKT show a strong pattern: all 5 previous sales at this ticker were well-timed at the 90-day mark, with subsequent declines ranging from -5.4% to -36.5%. The company posted a quarterly revenue of $97,835,000 but remains unprofitable with a net loss of $-7,816,000 in its most recent full fiscal year, though it maintains 26.1% annual revenue growth. The current stock price of $28.94 is -31.4% from the 52-week high of $42.22, suggesting Hill sold while the stock was already under pressure. His consistent pattern of well-timed exits at ALKT (5 of 5 prior 90-day outcomes negative) combined with the company's ongoing unprofitability warrants attention to whether this sale reflects confidence in the sale timing or signals emerging challenges at a loss-making firm.

CFO Bryan Hill sold 17,409 shares of ALKT at $30.41 on 2025-03-03; stock now $28.84, down 31.7% from 52-week high.

HILL W BRYAN (Chief Financial Officer) sold 17,409 shares at $30.41 on 2025-03-03, reducing his holdings from 468,029 shares to 450,620 shares. The stock has since declined to $28.84, trading 31.7% below its 52-week high of $42.22 and down 17.1% over the past 30 days. Across his same-ticker history at ALKT, prior sales on 2024-12-03, 2024-11-25, and 2024-11-21 all preceded 90-day declines ranging from -18.0% to -25.7%, indicating consistent pattern of well-timed exit execution at this company. The CFO's cross-ticker track record shows a 27.78% well-timed rate on prior sales, though that cross-ticker average 90-day return was +7.2%, contrasting with the persistent downward trajectory observed after each of his ALKT-specific sales. ALKT remains unprofitable (net income $-9.4M in the most recent quarter) despite 26.1% annual revenue growth, creating potential headwinds for valuation support.

CFO Bryan Hill sold 100,000 shares (100.0K shares) of ALKT at $33.43 on 2025-01-13; stock down 12.4% in 30 days and -17.8% from 52-week high.

Bryan Hill, CFO of Alkami Technology, executed a sale of 100,000 shares at $33.43 on 2025-01-13, reducing his holdings by 22.0% to 353.8K shares and raising $3.3M in proceeds. The sale occurred as ALKT has declined 12.4% over the past 30 days and sits 17.8% below its 52-week high of $42.22, while the company remains unprofitable with net income of $-9.4M against $85.9M in quarterly revenue. Hill's cross-ticker track record shows an average 90-day return of +16.7% following his prior sales (well-timed rate 0.00%), indicating his recent sells have generally been followed by stock appreciation rather than declines. His five prior sales at ALKT have produced mixed near-term results, with 30-day returns ranging from +2.9% to -5.4%, and insufficient time has elapsed to assess whether this latest sale precedes further weakness or a recovery.

CFO Hill W Bryan sold 100,000 ALKT shares at $39.77, reducing stake by 22.0% to 353,841 shares (value $3,976,850)

Hill W Bryan, Chief Financial Officer of Alkami Technology, sold 100,000 shares at $39.77 on 2024-12-16, a substantial 22.0% reduction of his pre-transaction holdings of 453,841 shares. The sale occurred near the 52-week high of $42.22 (at -10.1% from that peak), and the stock has gained 4.0% over the prior 30 days and 18.4% over 90 days. This represents the CFO's fifth sell transaction at ALKT within a three-week window (2024-11-18 through 2024-12-16), a rapid succession of dispositions despite the company's recent strong price momentum. While the company posted strong revenue growth of 29.6% year-over-year and a current market cap of $3,812,843,052.76, it remains unprofitable with a net loss of $9,442,000.00 in the latest quarter, which provides context for understanding executive liquidity decisions in a high-growth but unprofitable enterprise.

CFO Bryan Hill sold 17,807 shares of ALKT at $38.37 on Dec 3, 2024; stock has risen 8.5% in 30d and stock trades -6.1% from 52-week high.

CFO Bryan Hill sold 17,807 shares (17.8K shares) of Alkami Technology at $38.37 on 2024-12-03, reducing his holdings by 4.8% to 353.8K shares. The sale occurred near the lower end of the 52-week range ($22.31–$42.22) and the stock has since appreciated 8.5% in the 30 days following the transaction. Across his cross-ticker track record of 20 prior sells, Hill's sales have averaged +4.0% returns at 30 days and +14.9% at 90 days, with a 0.00% well-timed rate—indicating his prior sales have historically been followed by stock appreciation rather than declines. At Alkami specifically, Hill executed 5 prior trades, all sales; the most recent measurable outcome (2024-09-24) showed a +23.1% 30-day return. Alkami remains unprofitable (net income $-9.4M on $85.9M quarterly revenue) despite strong annual revenue growth of +29.6%, creating a backdrop where insider liquidity events warrant monitoring for any signal of confidence or concern in near-term fundamentals.

CFO sold 99,755 shares at $41.89; stock down 6.0% from 52-week high, company unprofitable with $-9.4M net income.

Hill W Bryan, Chief Financial Officer of Alkami Technology, sold 99,755 shares on 2024-11-25 at $41.89, reducing his holdings by 21.2% to 371,648 shares and generating $4,179,026.24 in proceeds. The transaction occurs as the stock trades at $39.69, down 6.0% from its 52-week high of $42.22, despite strong recent momentum (+21.7% over 90 days). Alkami remains unprofitable with a $-9.4M net income over its most recent full fiscal year, though the company is growing revenues at 29.6% annually. The CFO's cross-ticker historical track record shows a 0.00% well-timed selling rate, meaning his prior 20 sales across all holdings were not preceded by subsequent declines—a signal that his timing selection has not been predictive. At this specific ticker, three recent sales (2024-11-21 and 2024-11-18) have outcomes not yet measurable, while earlier September sales showed the stock rising 22-23% in the subsequent 30 days, opposite to what would signal foresight of a downturn.

ALKT CFO sells 110,250 shares in 2 transactions for $4,257,807.51; retains 471,403 shares post-transaction

Bryan sold 110,250 shares across two transactions on 2024-11-21 at blended average price $38.62, generating $4,257,807.51, while retaining 471,403 shares (471.4K shares) post-transaction. The sales represent a 19.0% reduction from pre-transaction holdings of 581,653 shares. Current price at $40.69 sits at the 52-week high (+0.0%), with the stock up 6.6% over 30 days and 20.7% over 90 days—performance that exceeds this insider's cross-ticker track record (avg 90d return after sells: +12.7%, well-timed rate: 0.00%). At the same ticker (ALKT), prior sales on 2024-11-18, 2024-09-24, and 2024-09-23 posted positive 30-day returns (+23.1%, +22.4%), suggesting the stock has broadly recovered after his recent sales. The company remains unprofitable (net income $-9.4M in the latest quarter, negative full-year result) despite strong revenue growth of +29.6% year-over-year, a backdrop that makes the timing and magnitude of this disposition material for shareholders.

CFO Bryan Hill sold 100,000 ALKT shares (17.5% of pre-transaction holdings) for $3.6M at $36.31 on 2024-11-18

Bryan Hill, CFO of Alkami Technology, executed a substantial sale of 100,000 shares worth $3,631,110.00, reducing his holdings by 17.5% to 471,403 shares. The sale occurred at $36.31, below the current price of $37.75 and notably -5.3% from the 52-week high of $39.86, suggesting the transaction was not executed at peak recent valuation. Reviewing his prior trades at ALKT, Hill has completed 5 recent sales (four within the past three months), with mixed near-term outcomes: three of his most recent 2024 sales generated 30-day gains of +23.1%, +22.4%, and +5.4%, while earlier sales in August showed 30-day declines of -8.0% and -9.4%. His cross-ticker track record shows 17 prior sells with an average 90-day return of +12.7% and a well-timed rate of 0.00%, indicating his historical sell decisions have not preceded stock declines. Against the backdrop of the company's significant unprofitability (net loss of $9.4M in the latest quarter despite strong 29.6% annual revenue growth), this represents a material portfolio reduction by a senior executive during a period of execution risk.